Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 11:07 PM
Ignite Modification Date: 2025-12-25 @ 8:39 PM
NCT ID: NCT04632069
Description: bradycardia defined as heart rate \<80beats per minute for \> 5 seconds; emesis
Frequency Threshold: 5
Time Frame: 36 days
Study: NCT04632069
Study Brief: NAC +taVNS in IDM Who Are Poor Oral Feeders
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
NAC + taVNS NAC will be given via nasogastric tube (n,g.) 75 or 100mg/kg n.g. q 6h, administered 1h before a feed, for a total of 14 days. taVNS will be administered to left ear during active sucking with 2 daily feedings starting after 4 days of NAC, continuing for 14 days. N acetyl cysteine + vagus nerve stimulation: NAC x 14 days, taVNS x 14 days 1 None 0 10 2 10 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
bradycardia SYSTEMATIC_ASSESSMENT Cardiac disorders None View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
emesis per day SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View